Hematopoietic Effects and Clinical Application of Granulopoietic Growth Factors

References

• Demetri G, Griffin J. Granulocyte Colony-Stimulating Factor and Its Receptor. Blood 1991; 78: 2791
   PubMed Web of Science ®Google Scholar
• Gasson J. Molecular Physiology of Granulocyte-Macrophage Colony-Stimulating Factor. BLOOD 1991; 77: 1131
   PubMed Web of Science ®Google Scholar
• Lieschke G, Burgess A. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New Engl J Med 1992; 327: 28
   PubMed Web of Science ®Google Scholar
• Dreger P, Haferlach T, Eckstein V, Jakobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609
   PubMed Web of Science ®Google Scholar
• Emerson S G. The stem cell model of hematopoiesis. Hematology: Basic principles and practice. 1:st ed., R Hoffman, E-J J Benz, S J Shattil, B Furie, H Cohen. Churchill Livingstone Inc., New York 1991; 72
   Google Scholar
• Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haematopoietic cells. Nature 1989; 339: 27
   PubMed Web of Science ®Google Scholar
• McCredie K, Hersh E M, Freireich E J. Cells Capable of Colony Formation in the Peripheral Blood of Man. Science 1971; 171: 293
   PubMed Web of Science ®Google Scholar
• Bender J, Unverzagt K, Walker D, Lee W, Van Epps D E, Smith D, Stewart C C, To L B. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991; 77: 2591
   PubMed Web of Science ®Google Scholar
• To L B, Haylock D N, Dowse T, Simmons P J, Trimboli S, Ashman L K, Juttner C A. A comparative study of the phenotype and proliferative capacity of peripheral (PB) CD34+ cells mobilized by four different protocols and those of steady-state PB and bone marrow CD34+ cells. Blood 1994; 84: 2930
   PubMed Web of Science ®Google Scholar
• Kessinger A, Armitage J O, Landmark J D, Weisenburger D D. Reconstitution av Human Hematopoietic Function with Autologous Cryperserved Circulating Stem Cells. Exp Hematol 1986; 14: 192
   PubMed Web of Science ®Google Scholar
• Robinson W, Mangalik A. The kinetics and regulation of granulopoiesis. Seminars in Hematology 1975; 12: 7
   Google Scholar
• Bainton D, Ullyot J, Farquhar M. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. Origin and content of azurophil and specific granules. J Exp Med 1971; 134: 907
   PubMed Web of Science ®Google Scholar
• Bodey G, Buckley M, Sathe Y, Freireich E. Quantitative relationshsips between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328
   PubMed Web of Science ®Google Scholar
• Butcher E. Leukocyte-endothelial cell adhesion as an active, multi-step process: A combinatorial mechanism for specificity and diversity in leukocyte targeting. Avd. Exp. Med. Biol 1992; 323: 181
   Google Scholar
• Springer T. Adhesion receptors of the immune system. Nature 1990; 346: 425
   PubMed Web of Science ®Google Scholar
• Xu S Y, Carlson M, Engström Å, Garcia R, Peterson C, Venge P. Purification and chracterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. The Scandinavian Journal of Clinical&Laboratory Investigation 1994; 54: 365
   PubMed Web of Science ®Google Scholar
• Olofsson T, Olsson I, Venge P, Elgefors B. Serum myeloperoxidase and lactoferrin in neutropenia. Scandinavian Journal of Haematology 1977; 18: 73
   PubMedGoogle Scholar
• Xu S Y, Peterson C, Carlson M, Venge M. The development of an assay for neutrophil lipocalin - to be used as a specific marker of neutrophil activity in vitro and in vivo. Journal of Immunological Methdos 1994; 171: 245
   PubMed Web of Science ®Google Scholar
• Öberg G, Venge P. Bone-marrow regeneration after therapy-induced hypoplasia monitored by serum measurements of lactoferrin, lysozyme and myeloperoxidase. Scand J of Haematology 1986; 37: 130
   PubMedGoogle Scholar
• Öberg G, Simonsson B, Smedmyr B, Tötterman T H, Venge P. Myeloid regeneration after bone-marrow transplantation monitored by serum measurements of myeloperoxidase, lysozyme and lactoferrin. Eur J of Haematology 1987; 38: 356
   PubMed Web of Science ®Google Scholar
• Pauksen K, Elfman L, Ulfgren A-K, Venge P. Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Bristish Journal of Haematology 1994; 88: 256
   PubMed Web of Science ®Google Scholar
• Xu S Y, Pauksen K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between bacterial and viral infections. The Scandinaivan Journal of Clinical&Laboratory Investigation 1995; 55: 125
   PubMed Web of Science ®Google Scholar
• Lopez A, Williamson J, Begley J GCG, Harlan J M, Klebanoff S J, Waltersdorph A, Wong G, Clark S C, Vadas M A. Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature neutrophil and eosinophil functions, surface receptor expression and survival. J Clin Invest 1986; 78: 1220
   PubMed Web of Science ®Google Scholar
• Stanley E, Lieschke G, Grail D, Metcalf D, Hodgson G, Gall J, Maher D, Cebon J, Sinickas V, Dunn A. Granulocyte-macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc natl Acad Sci USA 1994; 91: 5592
   PubMed Web of Science ®Google Scholar
• Gerhartz H, Engelhard M, Meusers P, Brittinger G, Wilmanns W, Schlimok G, Mueller P, Huhn D, Musch R, Siegert W, Gerhartz D, Hartlapp J, Thiel E, Huber C, Peschl C, Spann W, Emmerich B, Schadek C, Westerhausen M, Pees H-W, Radtke H, Engert A, Terhardt E, Schick H, Binder T, Fuchs R, Hasford J, Brandmeier R, Stern A, Jones T, Ehrlich H, Stein H, Parwaresch M, Tiemann M, Lennert K. Randomised, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphoma. Blood 1993; 82: 2329
   PubMed Web of Science ®Google Scholar
• Bradley T, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966; 44: 287
   PubMedGoogle Scholar
• Burgess A, Metcalf D. Characterisation of a serum factor stimulating the differentiation of myelomonocytic leukemia cells. International Journal of Cancer 1980; 26: 647
   PubMed Web of Science ®Google Scholar
• Nicola N, Metacalf D, Matsumoto M, Johnson G. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. Journal of Biological Chemistry 1983; 258: 9017
   PubMed Web of Science ®Google Scholar
• Souza L, Boone T, Gabrilove J, Lai P, Zsebo K, Murdock D, Chazin V, Bruszewski J, Lu H, Chen K, Barendt J, Platzer E, Moore M, Mertelsmann R, Welte K. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 1986; 232: 61
   PubMed Web of Science ®Google Scholar
• Nagata S, Tsuchiya M, Asano S, Kaziro Y, Xamazaki T, Yamamoto O, Hirato Y, Kubota N, Ohedd M, Nomura H, Ono M. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986; 319: 415
   PubMed Web of Science ®Google Scholar
• Bronchud M, Scarffe J, Thatcher N. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br. J Cancer 1987; 56: 809
   Google Scholar
• Oheda M, Hase S, Ono M. Structure of the sugar chains of recombinant human granulocyte colony-stimulating factor produced by Chinese hamster ovary cells. J Biochem 1988; 103: 544
   Google Scholar
• Oh-Eda M, Hasegawa M, Hattori K, Kuboniwa H, Kojima T, Orita T, Tumonou K, Yamazakai T, Ochi N. O-Linked Sugar Chain of Human Granulocyte Colony-stimulating Factor Protects against Polymerizatioin and Denaturation Allowing It to Retain Its Biological Activity. The Journal of Biological Chemistry 1990; 265: 11432
   PubMed Web of Science ®Google Scholar
• Kishita M. Stability of G-CSF in serum. The Clinical Report 1992; 26: 1
   Google Scholar
• Olsson I, Gullberg U, Iantz M, Richter J. The receptors for regulatory molecules of hematopoiesis. European Journal of Haematology 1992; 48: 1
   PubMed Web of Science ®Google Scholar
• Fukunaga R, Ishizaka-Ikeda E, Nagata S. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem 1990; 265: 14008
   PubMed Web of Science ®Google Scholar
• Dong F, van Buitenen C, Pouwels K, Hoefsloot L, Löwenberg B, Touw I. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 1993; 13: 7774
   PubMed Web of Science ®Google Scholar
• Löwenberg B, Touw I. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281
   PubMed Web of Science ®Google Scholar
• Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, Kamachi S. Serum granulocyte colony-stimulating factor levels in helathy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989; 73: 117
   PubMed Web of Science ®Google Scholar
• Lieschke G J, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler K J, Basu S, Zhan Y F, Dunn A R. Mice Lacking Granulocyte Colony-Stimulating Factor Have Chronic Neutropenia, Granulocyte and Macrophage Progenitor Cell Deficiency, and Impaired Neutrophil Mobilization. Blood 1994; 84: 1737
   PubMed Web of Science ®Google Scholar
• Begley C, Lopez A, Nicola N, Warren D, Vdas M, Sanderson C, Metcalf D. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 1986; 68: 162
   PubMed Web of Science ®Google Scholar
• Kerst M, de Haas M, van der Schoot E, Slaper-Cortenbach I, Kleijer M, von dem Borne A, van oers R. Recombinant Granulocyte Colony-Stimulating Factor Administration to Healthy Volunteers: Induction of Immunophenotypically and Functionally Altered Neutrophils via an Effect on Myeloid Progenitor Cells. Blood 1993; 82: 3265
   PubMed Web of Science ®Google Scholar
• Katoh M, Shirai T, Shikoshi K, Ishii M, Saito M, Kitigawa S. Neutrophil kinetics shortly after initial administration of recombinant granulocyte colony-stimulating factor: neutrophil alkaline phosphatase activity as an endogenous marker. Eur J Haematol 1992; 49: 19
   Google Scholar
• Lord B, Bronchud M, Owens S, Chang J, Howell A, Souza L, Dexter T. The kinetics om human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 1989; 86: 9499
   PubMed Web of Science ®Google Scholar
• Lord B I, Molineux G, Pojda Z, Souza L M, Mermod J J, Dexter T M. Myeloid Cell Kinetics in Mice Treated With Recombinant Interleukin-3, Granulocyte Colony-Stimulating Factor (CSF), Granulocyte-Macrophage CSF In Vivo. Blood 1991; 77: 2154
   PubMed Web of Science ®Google Scholar
• Bensinger W I, Price T H, Dale D C, Appelbaum F R, Clift R, Lilleby K, Williams B, Storb R, Thomas E D, Buckner D. The Effects of Daily Recombinant Human Granulocyte Colony-Stimulating Factor Administration on Normal Granulocyte Donors Undergoing Leukapheresis. Blood 1993; 81: 1883
   PubMed Web of Science ®Google Scholar
• Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden J, Platzer E. Neutrophils Express the High Affinity Receptor for IgG (FcgammaR1, CD64) After In Vivo Application of Recombinant Human Granulocyte Colony-Stimulating Factor. Blood 1991; 78: 885
   PubMed Web of Science ®Google Scholar
• Trillet-Lenoir V, Green J, Manegold C, Von Pawel J, Gatzemeier U, Lebeua B, Depierre A, Johnson P, Decoster G, Tomita D, Ewen C. Recombinant Granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 1993; 294: 319
   Google Scholar
• Gisselbrecht C, Prentice H G, Bacigalupo A, Biron P, Milpied N, Rubie H, Cunningham D, Legros M, Pico J L, Linch D C, Burnett A K, Scarffe J H, Siegert W, Yver A. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. The Lancet 1994; 343: 696
   PubMed Web of Science ®Google Scholar
• Sheridan W, Wolf M, Lusk J, Layton J E, Souza L, Morstyn G, Dodds A, Maher D, Green M, Fox R. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. The Lancet 1989; 891
   Google Scholar
• Dale D, Bonilla M, Davis M. A randomised controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81: 2496
   PubMed Web of Science ®Google Scholar
• Nelson S. Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the non-neutropenic host. Clin Infect Dis 1994; 18: S197
   Google Scholar
• Pizzo P. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1996; 328: 1323
   Google Scholar
• Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Ruasch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M J G. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. The New Engl of Medicine 1991; 325: 164
   PubMed Web of Science ®Google Scholar
• Dombret H, Chasttang C, Fenaux P, Reiffers J, Bordessoule D, Boubdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H, Yver A, Degos L. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. N Engl J Med 1995; 332: 1678
   PubMed Web of Science ®Google Scholar
• Ottman O, Hoelzer D, Gracien E. Concomitant colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia. Blood 1995; 86: 444
   PubMed Web of Science ®Google Scholar
• To L. Mobilizing and collecting blood stem cells. Blood stem transplants, R P Gale, C Juttner, P Henon. Cambridge University Press, New YorkUS 1994; 56
   Google Scholar
• Laterveer L, Lindley I, Heemskerk D, Camps J, Pauwels E, Willemze R, Fibber W. Rapid mobilization of hematopoietic prgoenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996; 87: 781
   PubMed Web of Science ®Google Scholar
• Richman C M, Weiner R S, Yankee R A. Increase in Circulating Stem Cells Following Chemotherapy in Man. Blood 1976; 47: 1031
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T, Nakamato B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc. Natl. Acad. Sci. USA 1993; 90: 9374
   PubMed Web of Science ®Google Scholar
• To L B, Sheppherd K M, Haylock D N, Dyson P G, Charles P, Thorp D L, Dale B M, Dart G W, Roberts M M, Sage R E, Juttner C A. Single High Doses of Cyclophophamide Enable the Collection of High Numbers of Hemopoietic Stem Cells from the Peripheral Blood. Exp. Hematology 1990; 18
   Google Scholar
• Pettengell R, Morgenstern G R, Woll P J, Chang J, Rowlands M, Young R, Radford J A, Scarffe J H, Testa N G, Crowther D. Peripheral Blood Progenitor Cell Transplantation in Lymphoma and Leukemia Using a Single Apheresis. Blood 1993; 82: 3770
   PubMed Web of Science ®Google Scholar
• Dührsen U, Villeval J-L, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074
   PubMed Web of Science ®Google Scholar
• Socinski M A, Cannistra S A, Elias A, Antman K H, Lowell S, Griffin J D. Granulocyte-Macrophage Colony Stimulating Factor Expands the Circulating Haemopoietic Progenitor Cell Compartment In Man. The Lancet May 1988; 28: 1194
   Google Scholar
• Sheridan W P, Begley C G, Juttner C A, Scer J, To L B, Maher D, McGrath K M, Morstyn G, Fox R M. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. The Lancet 1992; 339: 640
   PubMed Web of Science ®Google Scholar
• Lane T, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen L, Hardwick A, Moubayed M, Oldham F, Corringham R, Ho A. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Sakamaki S, Kohgo Y, Ohi S, Hirayama Y, Niitsu Y. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplantation 1993; 11: 103
   PubMed Web of Science ®Google Scholar
• Roberts A W, Metcalf D. Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol 1994; 22: 1156
   Google Scholar
• Stoppa A M, Blaise D, Viens P, Baume D, Mannoni P, Novakovitch G, David F A, Yver A, Maraninchi D. Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantation. Bone Marrow Transplantation 1994; 13: 541
   Google Scholar
• Bensinger W I, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825
   PubMed Web of Science ®Google Scholar
• Tjønnfjord G, Steen R, Evensen S, Thorsby E, Egeland T. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994; 84: 2795
   PubMed Web of Science ®Google Scholar
• Demuynck H, Pettengell R, de Campos E, Dexter T M, Testa N G. The Capacity of Peripheral Blood Stem Cells Mobilised with Chemotherapy plus G-CSF to Repopulate Irradiated Marrow Stroma in vitro is Similar to that of Bone Marrow. Eur J. Cancer 1992; 28: 381
   Google Scholar
• Molineux G, Pojda Z, Hampson I N, Lord B I, Dexter T M. Transplantation potential of peripheral blood stem cells induced by granulcyte colony-stimulating factor. Blood 1990; 76: 2153
   PubMed Web of Science ®Google Scholar
• Civin C, Strauss L, Brovall C, Fackler M, Schwartz J, Shaper J. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. The Journal of Immunology 1984; 133: 157
   PubMed Web of Science ®Google Scholar
• Krause D, Fackler M, Civin C, May W. Review: CD34: Structure, biology, and clinical utility. Blood 1996; 87: 1
   PubMed Web of Science ®Google Scholar
• Berenson R J, Bensinger W I, Hill R S, Andrews R G, Garcia-Lopez J, Kalamasz D F, Still B J, Spitzer G, Buckner C D, Bernstein I D, Thomas E D. Engraftments After Infusion of CD34+ Marrow Cells in Patients with Breast Cancer or Neuroblastoma. Blood 1991; 77: 1717
   PubMed Web of Science ®Google Scholar
• Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern A, Lansdorp P, Bonadonna G, Gianni A. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400
   PubMed Web of Science ®Google Scholar
• Bender J G, Lum L, Unverzagt K L, Lee W, Van Epps D, George S, Coon J, Ghalie R, McLeod B, Kaizer H, Williams S F. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors wih different regimens. Bone Marrow Transplantation 1994; 13: 479
   PubMed Web of Science ®Google Scholar
• Johnsen HE (for the laboratories associated to the Nordic Myeloma Study Group). Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor estimation in leukapheresis from multiple myeloma patients. Journal of Hematotherapy 1995; 4: 21
   Google Scholar
• Sutherland H J, Eaves C J, Eaves A C, Dragowska W, Lansdorp P M. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563
   PubMed Web of Science ®Google Scholar
• Baum C M, Weissman I, Tsukamoto A, Buckle A-M, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proceedings of the National Academy of Science, USA 1992; 89: 2804
   PubMed Web of Science ®Google Scholar
• Kessinger A, Armitage J, Smith D, Landmark J, Bierman P, Weisenburger D. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260
   PubMed Web of Science ®Google Scholar
• Roberts M M, To L B, Gillis D, Mundy J, Rawling C, Ng K, Juttner C A. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplantation 1993; 12: 469
   PubMed Web of Science ®Google Scholar
• Peters W P, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilberg C, Kurtzberg J. Comparative Effects of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) on Priming Peripheral Blood Progenitor Cells for Use with Autologous Bone Marrow After High-Dose Chemotherapy. Blood 1993; 81: 1709
   PubMed Web of Science ®Google Scholar
• Brugger W, Bross K, Glatt M, Weber F, Mertelsmann R, Kanz L. Mobilization of Tumor Cells and Hematopoietic Progenitor Cells Into Peripheral Blood of Patients with Solid Tumours. Blood 1994; 83: 636
   PubMed Web of Science ®Google Scholar
• Kernan N, Collins N, Juliano L, Cartagena T, Dupont B, O'Reilly R. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986; 68: 770
   PubMed Web of Science ®Google Scholar
• Pan L, Delmonte J, Jr., Jalonen C K, Ferrara J LM. Pretreatment of Donor Mice With Granulocyte Colony-Stimulating Factor Polarizes Donor T Lymphocytes Toward Type-2 Cytokine Production and Reduces Severity of Experimental Graft-Versus-Host Disease. Blood 1995; 86: 4422
   PubMed Web of Science ®Google Scholar
• Körbling M, Przepiorka D, Huh Y O, Engel H, van Besien K, Giralt S, Andersson B, Kleine H D, Seong D, Deisseroth A B, Andreeff M, Champlin R. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659
   PubMed Web of Science ®Google Scholar
• Bensinger W I, Weaver C H, Appelbaum F R, Rowley S, Demirer T, Sanders J, Storb R, Buckner C D. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655
   PubMed Web of Science ®Google Scholar
• Schmitz N, Dreger P, Suttorp M, Rohwedder E, Haferlach T, Löffler H, Hunter A, Russell N H. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666
   PubMed Web of Science ®Google Scholar